5Adenis A, Huet G, Zerimech F, Hecquet B, Balduyck M,Peyrat JP. Cathepsin B, L, and D activities in colorectal carcinomas: Relationship with clinico-pathological parameters.Cancer Lett 1995; 96:267-275.
6Herszenyi L, Farinati F, Plebani M, Carraro P, Roveroni G,De Paoli Cardin M, Naccarato R, Tulassay Z. Prognostic role of cysteine and serin proteases in gastric cancer. Orv Hetil 1996; 137:1637-1641.
7Siewinski M. Autologous cysteine peptidase inhibitors as potential anticancer drugs. Anti Cancer Drugs 1993; 4:97-98.
9Longnecker MP, Martin-Moreno JM, Knekt P, Nomura AM,Schober SE, Stahelin HB, Wald NJ, Gey KF, Willett WC. Serum alpha-tocopherol concentration in relation to subsequent colorectal cancer: pooled data from five cohorts. J Nat Cancer Inst 1992; 84:430-435.
10Prasad KN, Cohrs RJ, Sharma OK. Decreased expression of c-myc and H-ras oncogenes in vitamin E succinate induced morphologically differentiated murine B-16 melanoma cells in culture. Biochem Cell Biol 1990; 68:1250-1255.
